Alveolar macrophages from EVALI patients and e-cigarette users: a story of shifting phenotype

Authors:

Abstract
Exposure to e-cigarette vapors alters important biologic processes including phagocytosis, lipid metabolism, and cytokine activity in the airways and alveolar spaces. Little is known about the biologic mechanisms underpinning the conversion to e-cigarette, or vaping, product use-associated lung injury (EVALI) from normal e-cigarette use in otherwise healthy individuals. We compared cell populations and inflammatory immune populations from bronchoalveolar lavage fluid in individuals with EVALI to e-cigarette users without respiratory disease and healthy controls and found that e-cigarette users with EVALI demonstrate a neutrophilic inflammation with alveolar macrophages skewed towards inflammatory (M1) phenotype and cytokine profile. Comparatively, e-cigarette users without EVALI demonstrate lower inflammatory cytokine production and express features associated with a reparative (M2) phenotype. These data indicate macrophage-specific changes are occurring in e-cigarette users who develop EVALI.
Funding Information
  • U.S. Department of Veterans Affairs (IK2 BX4004219, I01BX001777)
  • National Institutes of Health (U01HL123018-06S1, U01HL123018-06S1, U01HL123018-06S1, 5T32HL105321, U01HL123018-06S1)

This publication has 42 references indexed in Scilit: